Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Sagaert

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|February 23, 2026
Myeloid-derived PD-L1 characterizes spatially organized immune architecture in colorectal cancerQian Wu, Stephanie Tissot, Allyson Peddle, et al.
Annals of Surgical Oncology|October 28, 2017
Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal MetastasesCharlotte E L Klaver, Nadine C M van Huijgevoort, Anthony de Buck van Overstraeten, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survivalGeert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Thorax|September 10, 2015
DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signatureEls Wauters, Wim Janssens, Johan Vansteenkiste, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2020
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 6, 2026
Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative reviewPieter Maerten, Albert Wolthuis, André D'Hoore, et al.
Plos One|November 19, 2013
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Sylvia Hartmann, Claudia Döring, Christina Jakobus, et al.
Clinical and Translational Radiation Oncology|August 22, 2022
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort studyPhilippe P Bulens, Lien Smets, Annelies Debucquoy, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Adenocarcinoma at the gastroesophageal junctionSahar Al-Haddad, Andrew C Chang, Gert De Hertogh, et al.
British Journal of Haematology|December 31, 2013
Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of EuropePatrick Adam, Piotr Czapiewski, Seba Colak, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|February 23, 2026
Myeloid-derived PD-L1 characterizes spatially organized immune architecture in colorectal cancerQian Wu, Stephanie Tissot, Allyson Peddle, et al.
Annals of Surgical Oncology|October 28, 2017
Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal MetastasesCharlotte E L Klaver, Nadine C M van Huijgevoort, Anthony de Buck van Overstraeten, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survivalGeert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Thorax|September 10, 2015
DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signatureEls Wauters, Wim Janssens, Johan Vansteenkiste, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2020
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 6, 2026
Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative reviewPieter Maerten, Albert Wolthuis, André D'Hoore, et al.
Plos One|November 19, 2013
Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Sylvia Hartmann, Claudia Döring, Christina Jakobus, et al.
Clinical and Translational Radiation Oncology|August 22, 2022
Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort studyPhilippe P Bulens, Lien Smets, Annelies Debucquoy, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Adenocarcinoma at the gastroesophageal junctionSahar Al-Haddad, Andrew C Chang, Gert De Hertogh, et al.
British Journal of Haematology|December 31, 2013
Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of EuropePatrick Adam, Piotr Czapiewski, Seba Colak, et al.
Pageof 10